Nuveen Asset Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $78.1M | Sell |
4,552,317
-2,025,560
| -31% | -$34.7M | 0.02% | 466 |
|
|
2024
Q3 | $131M | Sell |
6,577,877
-2,347,261
| -26% | -$46.9M | 0.04% | 355 |
|
|
2024
Q2 | $99.8M | Sell |
8,925,138
-1,536,238
| -15% | -$17.2M | 0.03% | 407 |
|
|
2024
Q1 | $69.1M | Sell |
10,461,376
-894,101
| -8% | -$5.9M | 0.02% | 531 |
|
|
2023
Q4 | $51.3M | Buy |
11,355,477
+669,543
| +6% | +$3.03M | 0.02% | 594 |
|
|
2023
Q3 | $38.3M | Buy |
10,685,934
+2,126,797
| +25% | +$7.61M | 0.01% | 680 |
|
|
2023
Q2 | $31.6M | Sell |
8,559,137
-473,176
| -5% | -$1.75M | 0.01% | 791 |
|
|
2023
Q1 | $29.9M | Buy |
9,032,313
+1,479,806
| +20% | +$4.9M | 0.01% | 792 |
|
|
2022
Q4 | $29.3M | Sell |
7,552,507
-1,151,226
| -13% | -$4.47M | 0.01% | 810 |
|
|
2022
Q3 | $21.2M | Buy |
8,703,733
+1,541,544
| +22% | +$3.75M | 0.01% | 972 |
|
|
2022
Q2 | $14.2M | Sell |
7,162,189
-432,751
| -6% | -$857K | 0.01% | 1284 |
|
|
2022
Q1 | $11.8M | Sell |
7,594,940
-3,017,660
| -28% | -$4.71M | ﹤0.01% | 1544 |
|
|
2021
Q4 | $15M | Buy |
10,612,600
+3,727,960
| +54% | +$5.26M | ﹤0.01% | 1426 |
|
|
2021
Q3 | $7.78M | Buy |
6,884,640
+980,981
| +17% | +$1.11M | ﹤0.01% | 1961 |
|
|
2021
Q2 | $9.45M | Sell |
5,903,659
-855,303
| -13% | -$1.37M | ﹤0.01% | 1905 |
|
|
2021
Q1 | $11.9M | Buy |
6,758,962
+6,502,025
| +2,531% | +$11.4M | ﹤0.01% | 1688 |
|
|
2020
Q4 | $501K | Buy |
256,937
+1,407
| +0.6% | +$2.74K | ﹤0.01% | 3043 |
|
|
2020
Q3 | $611K | Sell |
255,530
-119,214
| -32% | -$285K | ﹤0.01% | 2881 |
|
|
2020
Q2 | $1.1M | Sell |
374,744
-385,832
| -51% | -$1.13M | ﹤0.01% | 2587 |
|
|
2020
Q1 | $2.19M | Buy |
760,576
+481,876
| +173% | +$1.39M | ﹤0.01% | 2145 |
|
|
2019
Q4 | $1.12M | Buy |
278,700
+144,913
| +108% | +$580K | ﹤0.01% | 2647 |
|
|
2019
Q3 | $595K | Buy |
133,787
+64,693
| +94% | +$288K | ﹤0.01% | 2887 |
|
|
2019
Q2 | $268K | Buy |
+69,094
| New | +$268K | ﹤0.01% | 3115 |
|